![System.Func`1[System.String]](/siteassets/images/z-mckesson-logosicons/health-systems2.png)
Consider the four “P’s” of generic drugs that support the case for wider adoption of generics in the health system and beyond.
Biosimilars: How to Prepare for Your Future
Key areas that health systems should consider when adopting biosimilars
By
Date
July 12, 2022
By: McKesson RxO
Read time: 1 minute
Read our latest Q & A to help health systems navigate the world of biosimilars
Biosimilars are important to health system customers because of their ability to help manage chronic conditions at lower costs to patient and providers, but there are many key areas that health systems should consider when adopting biosimilars.
Download this informative Q & A to learn more about potential challenges, cost benefits, and how health systems can prepare for the future when it comes to biosimilars.
Learn how the McKesson RxO Utilization Analytics tool can help health system customers with their biosimilar utilization.
Related Stories
Download this checklist for an at-a-glance view of important considerations when modernizing your health system’s infusion service line.
Our Specialty Pharmacy Enablement (SPE) expert discusses 3 critical areas of access for the health system specialty pharmacy.
The most downloaded content by health system pharmacy leaders in August 2025.
With available labor resources dwindling and a shrinking pipeline, health systems must find creative solutions for better using the personnel and partnerships they have.
As payer dynamics shift, therapy pipelines grow, and leakage accelerates, health systems leaders should rethink what infusion care can and should be.
Expert insights into prioritizing 340B as a system-wide program in your health system.
The most downloaded content by health system pharmacy leaders in July 2025.
This interactive experience highlights key aspects of our SPE solutions, designed to help your health system achieve more.
The first in a series of interviews with our Specialty Pharmacy Enablement expert, Ginger Thorpe, covering important questions health systems should be asking.